Evidence map›Paper›PMID 27321923›Full record

ArticleNeuron2016

Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.

Sebum Lee, Yulei Shang, Stephanie A Redmond, Anatoly Urisman, Amy A Tang, Kathy H Li, Alma L Burlingame, Ryan A Pak, Ana Jovičić, Aaron D Gitler and 9 more

Registry-linked trialAbstract read
In one paragraph

Article in Neuron, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00821132 (Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.), which is not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00821132 completednot on this map

Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.

TypeobservationalSponsorNorthwestern UniversityRan1991 to 2023Enrolled13,521ConditionsAmyotrophic Lateral Sclerosis (ALS), Familial Amyotrophic Lateral Sclerosis, ALS With Frontotemporal Dementia (ALS/FTD), Lou Gehrig's DiseaseArmsGenetic study of ALS families
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Ubiquitin-specific peptidase-19 links TDP-43 aggregation to ER stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dual roles of UPRJournal of molecular medicine (Berlin, Germany) · 2023
    Review
  10. Review
  11. Article
  12. HIPK2 in the physiology of nervous system and its implications in neurological disorders.Biochimica et biophysica acta. Molecular cell research · 2023
    Review
  13. Article
  14. Article
  15. HIPK2 directs cell type-specific regulation of STAT3 transcriptional activity in Th17 cell differentiation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Sebum LeeDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA.
Yulei ShangDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA.
Stephanie A RedmondDepartment of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.
Anatoly UrismanDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA.
Amy A TangDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA.
Kathy H LiDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Ryan A PakDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA.
Ana JovičićDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Aaron D GitlerDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jinhua WangDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School & Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Nathanael S GrayDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School & Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
William W SeeleyDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
Teepu SiddiqueDivision of Neuromuscular Medicine and Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Eileen H BigioDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Virginia M-Y LeeDepartment of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
John Q TrojanowskiDepartment of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
Jonah R ChanDepartment of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.
Eric J HuangDepartment of Pathology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA; Pathology Service 113B, VA Medical Center, San Francisco, CA 94121, USA. Electronic address: eric.huang2@ucsf.edu.
University of California, San Francisco · USHarvard University · USNorthwestern University · USStanford University · USUniversity of Pennsylvania · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIGIO, EILEEN H. · 1996 to 2020
$28.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Pharmaco Response Signatures and Disease MechanismU54HG006097 · NHGRI · HARVARD MEDICAL SCHOOL · PI MITCHISON, TIMOTHY J, SORGER, PETER KARL · 2010 to 2013
$9.7M
Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATIONR01NS062796 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHAN, JONAH R · 2008 to 2018
$3.4M
Functional Screening of GPCR Small Molecule Libraries for Remyelination TherapiesR01NS095889 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAN, JONAH R · 2016 to 2020
$1.9M
Mechanisms of HIPK2 in neurodegenerationR01NS098516 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ERIC J · 2016 to 2020
$1.7M
Purchase of Q-Exactive Mass SpectrometerS10OD016229 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2013 to 2013
$507k
Cellular and Animal Models of FUS Mutations in ALSR21OD011915 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ERIC J · 2012 to 2013
$421k
Mouse models of neuroprotection in dopamine neuronsK26OD010927 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, ERIC J · 2012 to 2013
$307k
BLRD VA I01 BX001108BLRD VA I21 BX001625NHGRI NIH HHS U54 HG006097NIA NIH HHS P01 AG017586NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG013854NIA NIH HHS P50 AG023501NIGMS NIH HHS P41 GM103481NIH HHS K26 OD010927NIH HHS R21 OD011915NIH HHS S10 OD016229NINDS NIH HHS F31 NS081905NINDS NIH HHS R01 NS062796NINDS NIH HHS R01 NS095889NINDS NIH HHS R01 NS098516RRD VA I01 RX002133
6 · The paper itself

Abstract

Persistent accumulation of misfolded proteins causes endoplasmic reticulum (ER) stress, a prominent feature in many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Here we report the identification of homeodomain interacting protein kinase 2 (HIPK2) as the essential link that promotes ER-stress-induced cell death via the IRE1α-ASK1-JNK pathway. ER stress, induced by tunicamycin or SOD1(G93A), activates HIPK2 by phosphorylating highly conserved serine and threonine residues (S359/T360) within the activation loop of the HIPK2 kinase domain. In SOD1(G93A) mice, loss of HIPK2 delays disease onset, reduces cell death in spinal motor neurons, mitigates glial pathology, and improves survival. Remarkably, HIPK2 activation positively correlates with TDP-43 proteinopathy in NEFH-tTA/tetO-hTDP-43ΔNLS mice, sporadic ALS and C9ORF72 ALS, and blocking HIPK2 kinase activity protects motor neurons from TDP-43 cytotoxicity. These results reveal a previously unrecognized role of HIPK2 activation in ER-stress-mediated neurodegeneration and its potential role as a biomarker and therapeutic target for ALS. VIDEO ABSTRACT.

Indexed as

Amyotrophic Lateral SclerosisAnimalsBiomarkersCarrier ProteinsCell DeathDisease Models, AnimalDNA-Binding ProteinsEndoplasmic ReticulumMice, TransgenicMotor NeuronsNeurogliaProtein Serine-Threonine KinasesSpinal CordSuperoxide DismutaseBiomarkersCarrier ProteinsDNA-Binding ProteinsHipk2 protein, mouseProtein Serine-Threonine KinasesSuperoxide DismutaseTardbp protein, mouse

Identifiers

PMID27321923
PMCPMC4938715
OpenAlexW2441946812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.